Camlin Fine Sciences receives GST order with Rs 23.54 crore demand
K N Mishra
17/Mar/2026
What's covered under the Article:
-
Camlin Fine Sciences receives GST order demanding Rs 23.54 crore along with interest and penalty over alleged ineligible ITC claims.
-
The issue relates to outstanding trade payables beyond 180 days for multiple financial years under GST provisions and compliance rules.
-
Company states no material business impact and confirms plans to challenge the order through an appeal process.
Camlin Fine Sciences Gets GST Order with Rs 23.54 Crore Demand has emerged as a significant update in the CAMLINFINE latest news, drawing attention from investors and market participants tracking regulatory developments. The latest Camlin Fine Sciences GST notice relates to a tax demand raised by authorities concerning alleged irregularities in Input Tax Credit (ITC) claims.
As per the official disclosure under Regulation 30 of SEBI guidelines, Camlin Fine Sciences Limited has received an order from the Office of the Commissioner of CGST & Central Excise, Palghar Commissionerate. This development falls under the category of GST demand India company news and highlights ongoing scrutiny of corporate tax compliance under the Goods and Services Tax framework.
The CGST order Camlin Fine Sciences specifies that the company has been issued an Order-in-Original by the Additional Commissioner, outlining a total demand of Rs. 23,54,15,880. This includes disallowance of ineligible Input Tax Credit (ITC) along with applicable interest and penalties.
Breaking down the demand, the order includes IGST of Rs. 7.63 crore, CGST of Rs. 7.95 crore, and SGST of Rs. 7.95 crore, all forming part of the total tax liability. Additionally, interest has been levied under relevant provisions, and a penalty equivalent to the tax demand amount has been imposed under Section 74(1) of the CGST Act, 2017.
The core issue in this input tax credit ITC issue India relates to the alleged availment of ineligible ITC linked to trade payables that remained outstanding for more than 180 days. The period under review spans from FY 2019-20 to FY 2022-23, indicating a multi-year compliance concern.
Under GST laws, businesses are required to reverse ITC if payments to suppliers are not made within a specified timeframe, typically 180 days. The authorities have alleged that the company did not comply with these provisions, leading to the issuance of the order.
This development is part of broader stock market regulatory news India, where listed companies are required to disclose significant regulatory actions to stock exchanges. Accordingly, Camlin Fine Sciences has informed both the Bombay Stock Exchange and the National Stock Exchange under SEBI disclosure Regulation 30 news requirements.
Despite the substantial tax demand, the company has clarified that there is no material impact on its financial, operational, or other business activities. This statement is important for investors, as it indicates that the company believes the issue can be managed without affecting its core operations.
The Camlin Fine Sciences tax penalty has been imposed under stringent provisions of the GST law, particularly Section 74, which deals with cases involving alleged fraud, misstatement, or suppression of facts. However, it is important to note that such orders are subject to appeal and further legal scrutiny.
In response to the order, Camlin Fine Sciences Limited has stated that it is in the process of filing an appeal. This is a common course of action in corporate compliance India GST case scenarios, where companies challenge tax demands based on their interpretation of the law and supporting documentation.
The Indian stock exchange announcements framework ensures transparency by requiring companies to promptly disclose such developments. This helps investors make informed decisions and maintains the integrity of the financial markets.
From a broader perspective, this case highlights the complexities involved in GST compliance, especially for large organisations with extensive supply chains and multiple transactions. Issues related to ITC claims, documentation, and payment timelines are among the most common areas of dispute under GST.
The GST demand India company news also underscores the importance of robust internal controls and compliance systems. Companies are increasingly investing in technology and expertise to ensure adherence to tax regulations and minimise the risk of disputes.
The CAMLINFINE latest news is particularly relevant for stakeholders in the specialty chemicals sector, as it reflects regulatory challenges that may impact the industry. While the company has assured that there is no immediate operational impact, the outcome of the appeal process will be closely watched.
The stock market regulatory news India environment has become more stringent in recent years, with authorities focusing on improving compliance and reducing tax evasion. This has led to increased scrutiny and enforcement actions across sectors.
In such a scenario, the role of corporate governance becomes critical. Timely disclosures, transparent communication, and proactive engagement with regulators are essential for maintaining investor confidence.
The Camlin Fine Sciences GST notice also highlights the need for clarity in GST provisions and consistent interpretation of rules. Differences in interpretation can often lead to disputes, requiring resolution through legal channels.
The company’s decision to appeal indicates its confidence in its position and willingness to pursue appropriate legal remedies. The appellate process will involve a detailed examination of facts, documentation, and legal arguments before a final decision is reached.
In conclusion, Camlin Fine Sciences Gets GST Order with Rs 23.54 Crore Demand is a notable development in the Indian stock exchange announcements and corporate compliance India GST case landscape. While the tax demand and penalty are significant, the company’s assurance of no material impact and its plan to appeal provide some reassurance to stakeholders.
As the situation evolves, the CAMLINFINE latest news will continue to be closely monitored by investors, analysts, and industry participants. The case serves as a reminder of the importance of compliance, transparency, and effective risk management in today’s regulatory environment.
Join our Telegram Channel for Latest News and Regular Updates.
Start your Mutual Fund Journey by Opening Free Account in Asset Plus.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.